Clinical Trial

M-Gard Particulate EW Efficacy Study on Seasonal Allergic Rhinitis

Completed Phase 2
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to assess the efficacy and safety of M-Gard supplementation for alleviating the symptoms of allergic rhinitis.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2025-03-27; most recent amendment 2026-03-04.
Status change: Recruiting → Completed 2026-03-04
Status change: Not Yet Recruiting → Recruiting 2025-06-18
Trial Details
NCT Number NCT06907680
Lead Sponsor RDC Clinical Pty Ltd
Collaborators: Lallemand Bio-Ingredients
Conditions Allergic Rhinitis Due to Grass Pollens
Enrollment 20 participants
Start Date 2025-06-27
Primary Completion 2026-01-29 (estimated)
Study Completion 2026-01-29 (estimated)
Updated on ClinicalTrials.gov 2026-03-06